Milestone Pharmaceuticals Inc.
MIST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001408443
No open-market purchases or sales by Milestone Pharmaceuticals Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $66.4M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Milestone Pharmaceuticals Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 56 | 50 | −6 |
| Shares | 24.2M | 21.7M | −2.45M (−10.1%) |
| Value | $96.9M | $85.5M | −$11.4M (−11.7%) |
New holders (6)
Institutions that held Milestone Pharmaceuticals Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Gsa Capital Partners LLP | 99,768 | $393.0K | 0.04% |
| Clear Creek Financial Management, LLC | 35,929 | $141.6K | 0.03% |
| HighTower Advisors, LLC | 26,200 | $103.0K | 0.00% |
| PVG Asset Management Corp | 15,835 | $62.4K | 0.20% |
| Susquehanna International Group, LLP | 12,386 | $48.8K | 0.00% |
| ICA Group Wealth Management, LLC | 100 | $394 | 0.00% |
Sold out (12)
Institutions that held Milestone Pharmaceuticals Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Braidwell LP | 1,164,849 | $4.61M |
| Pura Vida Investments, LLC | 371,788 | $1.47M |
| Bank of Montreal | 152,636 | $610.5K |
| Walleye Capital LLC | 81,660 | $323.4K |
| PEAK6 Investments LLC | 39,956 | $158.2K |
| Virtu Financial LLC | 15,774 | $62.0K |
| Beta Wealth Group, Inc. | 14,127 | $55.9K |
| Corton Capital Inc. | 13,728 | $54.4K |
| Delphia (USA) Inc. | 12,610 | $49.9K |
| Royal Bank of Canada | 2,000 | $8.00K |
| Cutler Group LP | 600 | $2.00K |
| The PNC Financial Services Group, Inc. | 137 | $543 |